arrow_back Back Filing freshness 10-Q Q2 FY2026 SEC EDGAR

cbdMD, Inc.

YCBD
$0.57 ▲ +0.01 (+1.34%) at close
Energy ·Perfumes, Cosmetics & Other Toilet Preparations ·USPerfumes, Cosmetics & Other Toilet Preparations
40 Visible periods
32 Metrics
Peer-ranked Benchmarks
Price Chart
25
Health
Poor
Bearish
auto_awesome

Analytical Summary

cbdMD, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $6.0M
Dividend Yield
Revenue Growth 18.8%
Op. Margin -14.2%
ROIC -6.8%
FCF / Share $-0.07
Trailing P/E
Price / Book 0.6x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

40-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$5.64M
↑ +18.8%
Net Income Profit after all expenses
$-797.98K
↓ -181.8%
Operating Margin Operating profit as % of sales
-14.2%
↓ -148.8% 14th
FCF / Share Free cash flow per share
$-0.07
↑ +35.8%
Long-Term Debt Long-term obligations
$0.00
↓ -100.0%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
14
Returns
24
Cash Quality
54

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 11 years · 40 quarters